Non-small-cell lung cancer: how to manage BRAF-mutated disease

BRAF mutations are reported in about 3–5% of non-small-cell lung cancer (NSCLC), almost exclusively in adenocarcinoma histology, and are classified into three different classes. The segmentation of BRAF mutations into V600 (class 1) and non-V600 (classes 2 and 3) relies on their biological character...

Descripción completa

Detalles Bibliográficos
Autores principales: Guaitoli, Giorgia, Zullo, Lodovica, Tiseo, Marcello, Dankner, Matthew, Rose, April AN, Facchinetti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166262/
https://www.ncbi.nlm.nih.gov/pubmed/37168877
http://dx.doi.org/10.7573/dic.2022-11-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166262/
https://www.ncbi.nlm.nih.gov/pubmed/37168877
http://dx.doi.org/10.7573/dic.2022-11-3

Ejemplares similares